|
1
|
Fu Z, Wang M, Potter D, Miziorko HM and
Kim JJ: The structure of a binary complex between a mammalian
mevalonate kinase and ATP: Insights into the reaction mechanism and
human inherited disease. J Biol Chem. 277:18134–18142.
2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Houten SM, Wanders RJ and Waterham HR:
Biochemical and genetic aspects of mevalonate kinase and its
deficiency. Biochim Biophys Acta. 1529:19–32. 2000.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bouwstra JA and Ponec M: The skin barrier
in healthy and diseased state. Biochim Biophys Acta.
1758:2080–2095. 2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhao Y, Gartner U, Smith FJ and McLean WH:
Statins downregulate K6a promoter activity: A possible therapeutic
avenue for pachyonychia congenita. J Invest Dermatol.
131:1045–1052. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang SQ, Jiang T, Li M, Zhang X, Ren YQ,
Wei SC, Sun LD, Cheng H, Li Y, Yin XY, et al: Exome sequencing
identifies MVK mutations in disseminated superficial actinic
porokeratosis. Nat Genet. 44:1156–1160. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Shen CS, Tabata K, Matsuki M, Goto T,
Yokochi T and Yamanishi K: Premature apoptosis of keratinocytes and
the dysregulation of keratinization in porokeratosis. Br J
Dermatol. 147:498–502. 2002.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alaei P, MacNulty EE and Ryder NS:
Inhibition of protein prenylation down-regulates signalling by
inflammatory mediators in human keratinocytes. Biochem Biophys Res
Commun. 222:133–138. 1996.PubMed/NCBI View Article : Google Scholar
|
|
8
|
McTaggart SJ: Isoprenylated proteins. Cell
Mol Life Sci. 63:255–267. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xia Z, Tan MM, Wong WW, Dimitroulakos J,
Minden MD and Penn LZ: Blocking protein geranylgeranylation is
essential for lovastatin-induced apoptosis of human acute myeloid
leukemia cells. Leukemia. 15:1398–1407. 2001.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Moravcová M, Libra A, Dvořáková J, Víšková
A, Muthný T, Velebný V and Kubala L: Modulation of keratin 1, 10
and involucrin expression as part of the complex response of the
human keratinocyte cell line HaCaT to ultraviolet radiation.
Interdiscip Toxicol. 6:203–208. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ichikawa E, Watanabe S and Takahashi H:
Keratin and involucrin expression in discoid lupus erythematosus
and lichen planus. Arch Dermatol Res. 289:519–526. 1997.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Poumay Y, Herphelin F, Smits P, De Potter
IY and Pittelkow MR: High-cell-density phorbol ester and retinoic
acid upregulate involucrin and downregulate suprabasal keratin 10
in autocrine cultures of human epidermal keratinocytes. Mol Cell
Biol Res Commun. 2:138–144. 1999.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ichikawa E, Ohnishi T and Watanabe S:
Expression of keratin and involucrin in keratoacanthoma: An
immunohistochemical aid to diagnosis. J Dermatol Sci. 34:115–117.
2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ivanova P, Atanasova G, Poumay Y and Mitev
V: Knockdown of PKD1 in normal human epidermal keratinocytes
increases mRNA expression of keratin 10 and involucrin: Early
markers of keratinocyte differentiation. Arch Dermatol Res.
300:139–145. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pastar I, Stojadinovic O, Sawaya AP, Stone
RC, Lindley LE, Ojeh N, Vukelic S, Samuels HH and Tomic-Canic M:
Skin metabolite, farnesyl pyrophosphate, regulates epidermal
response to inflammation, oxidative stress, and migration. J Cell
Physiol. 231:2452–2463. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tricarico PM, Romeo A, Gratton R, Crovella
S and Celsi F: Lack of prenylated proteins, autophagy impairment
and apoptosis in SH-SY5Y neuronal cell model of mevalonate kinase
deficiency. Cell Physiol Biochem. 41:1649–1660. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tricarico PM, Marcuzzi A, Piscianz E,
Monasta L, Crovella S and Kleiner G: Mevalonate kinase deficiency
and neuroinflammation: Balance between apoptosis and pyroptosis.
Int J Mol Sci. 14:23274–23288. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yanae M, Tsubaki M, Satou T, Itoh T, Imano
M, Yamazoe Y and Nishida S: Statin-induced apoptosis via the
suppression of ERK1/2 and Akt activation by inhibition of the
geranylgeranyl-pyrophosphate biosynthesis in glioblastoma. J Exp
Clin Cancer Res. 30(74)2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jurczyluk J, Munoz MA, Skinner OP, Chai
RC, Ali N, Palendira U, Quinn JM, Preston A, Tangye SG, Brown AJ,
et al: Mevalonate kinase deficiency leads to decreased prenylation
of Rab GTPases. Immunol Cell Biol. 94:994–999. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Munoz MA, Jurczyluk J, Mehr S, Chai RC,
Arts RJW, Sheu A, McMahon C, Center JR, Singh-Grewal D, Chaitow J,
et al: Defective protein prenylation is a diagnostic biomarker of
mevalonate kinase deficiency. J Allergy Clin Immunol. 140:873–875,
e876. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Lacbay CM, Waller DD, Park J, Gómez Palou
M, Vincent F, Huang XF, Ta V, Berghuis AM, Sebag M and Tsantrizos
YS: Unraveling the Prenylation-cancer paradox in multiple myeloma
with novel geranylgeranyl pyrophosphate synthase (GGPPS)
inhibitors. J Med Chem. 61:6904–6917. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Satoh K, Ichihara K, Landon EJ, Inagami T
and Tang H: 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors
block calcium-dependent tyrosine kinase Pyk2 activation by
angiotensin II in vascular endothelial cells. involvement of
geranylgeranylation of small G protein Rap1. J Biol Chem.
276:15761–15767. 2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wassmann S, Laufs U, Bäumer AT, Müller K,
Konkol C, Sauer H, Böhm M and Nickenig G: Inhibition of
geranylgeranylation reduces angiotensin II-mediated free radical
production in vascular smooth muscle cells: Involvement of
angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol.
59:646–654. 2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Waiczies S, Bendix I, Prozorovski T,
Ratner M, Nazarenko I, Pfueller CF, Brandt AU, Herz J, Brocke S,
Ullrich O and Zipp F: Geranylgeranylation but not GTP loading
determines rho migratory function in T cells. J Immunol.
179:6024–6032. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kusama T, Mukai M, Tatsuta M, Nakamura H
and Inoue M: Inhibition of transendothelial migration and invasion
of human breast cancer cells by preventing geranylgeranylation of
Rho. Int J Oncol. 29:217–223. 2006.PubMed/NCBI
|
|
27
|
Jiang C, Diao F, Sang YJ, Xu N, Zhu RL,
Wang XX, Chen Z, Tao WW, Yao B, Sun HX, et al: GGPP-mediated
protein geranylgeranylation in oocyte is essential for the
establishment of oocyte-granulosa cell communication and
primary-secondary follicle transition in mouse ovary. PLoS Genet.
13(e1006535)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fuchs D, Berges C, Opelz G, Daniel V and
Naujokat C: HMG-CoA reductase inhibitor simvastatin overcomes
bortezomib-induced apoptosis resistance by disrupting a
geranylgeranyl pyrophosphate-dependent survival pathway. Biochem
Biophys Res Commun. 374:309–314. 2008.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yokoyama K, Zimmerman K, Scholten J and
Gelb MH: Differential prenyl pyrophosphate binding to mammalian
protein geranylgeranyltransferase-I and protein farnesyltransferase
and its consequence on the specificity of protein prenylation. J
Biol Chem. 272:3944–3952. 1997.PubMed/NCBI View Article : Google Scholar
|
